Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$31.71 - $38.95 $342,404 - $420,582
-10,798 Reduced 61.34%
6,806 $263,000
Q3 2023

Nov 14, 2023

BUY
$37.32 - $49.29 $656,981 - $867,701
17,604 New
17,604 $664,000
Q1 2023

May 15, 2023

BUY
$37.58 - $52.57 $364,375 - $509,718
9,696 Added 100.83%
19,312 $783,000
Q4 2022

Feb 14, 2023

BUY
$49.7 - $57.71 $109,240 - $126,846
2,198 Added 29.63%
9,616 $490,000
Q3 2022

Nov 14, 2022

BUY
$53.86 - $66.8 $156,463 - $194,054
2,905 Added 64.37%
7,418 $400,000
Q2 2022

Aug 15, 2022

SELL
$63.83 - $80.0 $173,809 - $217,840
-2,723 Reduced 37.63%
4,513 $290,000
Q4 2021

Feb 14, 2022

BUY
$74.57 - $87.19 $539,588 - $630,906
7,236 New
7,236 $621,000
Q3 2021

Nov 15, 2021

SELL
$73.77 - $83.61 $367,374 - $416,377
-4,980 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$80.5 - $88.01 $209,622 - $229,178
2,604 Added 109.6%
4,980 $401,000
Q1 2021

May 17, 2021

SELL
$76.38 - $86.03 $46,591 - $52,478
-610 Reduced 20.43%
2,376 $200,000
Q4 2020

Feb 16, 2021

SELL
$75.39 - $82.36 $216,067 - $236,043
-2,866 Reduced 48.97%
2,986 $240,000
Q3 2020

Nov 16, 2020

SELL
$78.33 - $90.73 $1.99 Million - $2.3 Million
-25,348 Reduced 81.24%
5,852 $471,000
Q2 2020

Aug 14, 2020

BUY
$78.66 - $94.14 $1.52 Million - $1.82 Million
19,288 Added 161.92%
31,200 $2.69 Million
Q4 2019

Feb 14, 2020

BUY
$76.7 - $88.45 $411,418 - $474,445
5,364 Added 81.92%
11,912 $996,000
Q4 2017

Feb 14, 2018

BUY
$61.45 - $66.05 $173,043 - $185,996
2,816 Added 75.46%
6,548 $423,000
Q3 2017

Nov 14, 2017

BUY
$59.5 - $64.61 $222,054 - $241,124
3,732
3,732 $234,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $18.3B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.